semaglutide cardiovascular trial news The SELECT - A New Era in Obesity and Care Updates in Medicine | Not

Understanding why researchers pursued this neurotrophic compound for AD, what preclinical evidence showed, and why the clinical translation ultimately failed provides crucial context for anyone evaluating Dihexa's potential

People with certain medical histories may need extra caution or a different approach

Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity

Official Journal of the European Union 55:L 83/140-141

A large observational study published in Diabetologia in 2022 looked at GLP-1 receptor agonist use in humans and found no statistically significant increase in thyroid cancer risk